NCT06808568Available不适用
Expanded Access Program (EAP) STIMULAN VG
试验速览
- 阶段
- 不适用
- 状态
- Available
研究概览
简要总结
Individual (single) patient expanded access may be considered.
详细描述
Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers.
Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient.
Please contact expandedaccess@biocomposites.com for more information.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
Available
不适用
Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 MutationAdvanced Non-small Cell Lung CancerCancerNCT06761976Bayer
Available
不适用
Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's DiseaseNon-healing WoundThromboangiitis ObliteransNCT04914247Actelion
No Longer Available
不适用
Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other TreatmentsCOVID-19NCT06004128Invivyd, Inc.
Unknown
不适用
Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)Lupus Erythematosus SystemNCT04907175Hope Biosciences Research Foundation
No Longer Available
不适用
Individual Patient Expanded Access Gilteritinib (ASP2215)AMLNCT03315299Etan Orgel